2-Cyclopropyloxazole-4-carboxylic acid

Catalog No.: 
ACJMZO256
CAS No.: 
1060816-04-7
Molecular Formula: 
C7H7NO3
Molecular Weight: 
153.14
2-Cyclopropyloxazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$92.00In stockIn stock
250mg95%$111.00In stockIn stock
1g95%$278.00In stockIn stock
5g95%$1348.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyclopropyloxazole-4-carboxylic acid
IUPAC Name2-cyclopropyloxazole-4-carboxylic acid
MDL No.MFCD12026856
Molecular FormulaC7H7NO3
Molecular Weight153.14
SMILESO=C(C1=COC(C2CC2)=N1)O
InChI KeyBDAWHHUYCSZZAG-UHFFFAOYSA-N
Synonym2-cyclopropyl-1,3-oxazole-4-carboxylic acid(SALTDATA: FREE);2-Cyclopropyl-4-oxazolecarboxylic Acid;2-cyclopropyloxazole-4-carboxylic acid;4-Oxazolecarboxylic acid, 2-cyclopropyl-;2-cyclopropyl-1,3-oxazole-4-carboxylic acid(SALTDATA;2-cyclopropyl-1,3-oxazole-4-carboxylic acid;2-CYCLOPROPYL-1,3-OXAZOLE-4-
CAS No.1060816-04-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJMZO256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJMZO256 route product structure diagram
    ACJMZO2561060816-04-7In Stock
Inquiry

2. ACJMZO256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJMZO256 route product structure diagram
    ACJMZO2561060816-04-7In Stock
Inquiry

3. ACJMZO256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJMZO256 route product structure diagram
    ACJMZO2561060816-04-7In Stock
Inquiry

Comments (0)